SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the community discusses the implications of the company's recent Phase III trial failure for its Alzheimer's drug, with some investors expressing disappointment while others see it as an opportunity to buy. Despite the setback, there is optimism surrounding Novo Nordisk's position in the weight loss market, particularly with the potential upcoming approval of its oral Wegovy pill and comparison of CagriSema vs Zepbound study results.

Pony.ai, Inc. develops artificial intelligence-based robot designed for autonomous driving. The firm's software algorithms and infrastructure enables a vehicle to perceive its surroundings, predict what others will do, and maneuver itself accordingly. The company was founded by Jun Peng and Tian Cheng Lou in November 4, 2016 and is headquartered in Guangzhou, China.

Pony AI Inc. - ADR

Pony AI Inc

Pony AI is trending due to news of expanded robotaxi operations and partnerships, including a recent permit in Shanghai. The community is weighing the company's growth prospects against its financial performance, especially regarding profitability targets. Broader discussions involve comparing Pony AI to competitors in the autonomous driving space and assessing the impact of these developments on its market position.

Diginex Ltd. (Hong Kong) is a blockchain financial services and technology company. Its products include diginexESG, diginexLUMEN, diginexAPPRISE, diginexLUMEN Pro, and CSRD framework. The company was founded by Miles Christian Pelham on May 15, 2020 and is headquartered in London, the United Kingdom.

Diginex Ltd.

DGNX is trending due to its recent acquisition of The Remedy Project, sparking discussions about the company's expansion into human-rights remediation. The community is also actively analyzing potential trading strategies based on historical patterns of similar stocks. Options traders are closely monitoring put contracts, anticipating potential downside amidst the volatility.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is trending due to strong Q3 2025 earnings, highlighted by a 144.3% YoY revenue increase and significant growth in robotaxi revenue, with community members noting global expansion and regulatory milestones in the UAE and Switzerland. Investors are focused on WeRide's progress toward deploying hundreds of thousands of robotaxis by 2030 and its partnerships with companies like Bosch, Uber, and Grab. The conversation also includes comparisons to competitor Pony.ai, whose stock performance and institutional ownership are being weighed against WeRide's recent gains and expansion efforts.

Monad

Monad is trending as users discuss its upcoming launch and token distribution, particularly excitement around receiving tokens from the Coinbase presale. The community is actively speculating on potential price movements and strategies, with some comparing it to other recent launches. There's also discussion around the mainnet launch date.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending amid mixed sentiment, as discussions range from its ties to controversial figures to its evolving stance on cryptocurrency and potential competition with Bitcoin. The community is actively debating JPMorgan's investment strategies, alleged market manipulation, and the implications of its exploration of blockchain technology and stablecoins. Additionally, some traders are monitoring technical indicators to predict JPM's short-term price movements, while others are discussing potential investigations and regulatory scrutiny.

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.

Alvotech

Alvotech ($ALVO) is trending following the announcement of European approval for AVT03, a biosimilar to Prolia and Xgeva, used in bone disease treatment, sparking bullish sentiment. Despite some community concerns about cash flow and previous manufacturing setbacks, the biosimilar's approval and analyst upgrades are fueling optimism. Discussions center on the company's potential in the biosimilar market and strategic partnerships.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending as the stock price rises following news of its AI integration with Open AI, which is expected to enhance merchant and customer experiences, with some analysts predicting a significant price target increase. However, some community members are skeptical about the sustainability of Shopify's growth, citing competition and valuation concerns, while others point to the company's strong position in the e-commerce sector and potential for further gains.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi-Aventis ($SNY) is trending amid speculation surrounding potential acquisitions, particularly in the MASH and obesity spaces, with $ALT, $GUTS, and $IVA being mentioned as possible targets. Community discussions revolve around the company's pipeline expansion needs and potential partnerships, with some users highlighting data integrity concerns around one of the speculated targets. The broader context involves Sanofi's strategic moves to strengthen its immunology and vaccine portfolio.

mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022, and is headquartered in Hong Kong.

mF International Ltd - Ordinary Shares - Class A

mF International Ltd

MFI is trending due to its recent $500M private placement aimed at building a Bitcoin Cash treasury, fueling speculation about a potential pivot into crypto equity. Community members are discussing the involvement of a Chinese billionaire and the possibility of MFI becoming a major player in the crypto space. The stock's volatile price action and small float are contributing to the heightened interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oprah Winfrey-Backed Wellness Stock Stumbles As GLP-1 Boom Reshapes Consumer Habits: Growth Score Plummets

Prominent weight-loss and wellness company, WW International Inc. (NASDAQ: WW), backed by renowned talk show host Oprah Winfrey, has seen better days, with the company filing for bankruptcy early...

WW International (NASDAQ:WW) Downgraded to "Sell" Rating by Wall Street Zen

Wall Street Zen cut WW International from a "hold" rating to a "sell" rating in a report on Saturday...

WW International (NASDAQ:WW) Releases Quarterly Earnings Results, Misses Expectations By $0.30 EPS

WW International (NASDAQ:WW - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.44) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.30...

<ul class="summary-bullets"><li>WeightWatchers partnered with Amazon Pharmacy to expand access to weight-loss medications. &nbsp;</li><li>Members get real-time drug availability, automatic discounts, and fast delivery.</li></ul>WW International, Inc. (WW), known as WeightWatchers, has partnered with Amazon Pharmacy to make prescription access to weight management drugs faster and more affordable.&nbsp;<h2 class="st-heading-2">Simplifying Access To Weight-Loss Medications</h2>The collaboration enables WeightWatchers Clinic members to view real-time drug availability, compare delivery options, and utilize Amazon Pharmacy for fulfillment, thereby ensuring greater speed and convenience.&nbsp;The partnership addresses growing demand for weight management medications by leveraging Amazon’s established pharmacy infrastructure.&nbsp;Following the announcement,<a href="https://stocktwits.com/symbol/WW"> WW International stock</a> traded over 4% higher in Monday’s premarket. On Stocktwits, retail sentiment around the stock improved to ‘neutral’ from ‘bearish’ the previous day amid ‘high’ message volume levels.&nbsp;<h2 class="st-heading-2">Reducing Costs And Logistical Hurdles</h2>Through this integration, Amazon Pharmacy applies manufacturer-sponsored savings directly at checkout, removing the need for manual coupon entry or enrollment.&nbsp;Prime members receive free two-day delivery, with same-day service available in select areas. This approach aims to reduce costs and logistical hurdles, ensuring members can receive treatment without delays.<blockquote>"At WeightWatchers, we're committed to making it simpler and faster to access the weight management medications they need, and our collaboration with Amazon Pharmacy does exactly that."&nbsp;- Jon Volkmann, COO, WeightWatchers.&nbsp;</blockquote>"By delivering speed, reliability, and convenience we’re helping members stay focused on their health goals, not on pharmacy logistics,” he said.WeightWatchers’ clinical model combines medication with structured nutrition programs, behavior modification, and community-based support. A recent WeightWatchers Clinic study showed members lost an average of 21% of their body weight over 12 months, outperforming comparable telehealth programs and clinical trials.WeightWatchers stock has lost 0.3% since its relisting on Nasdaq in July.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-gral-stock-rising-today/ch6CMe0R3YL">Why Is GRAL Stock Rising Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the WeightWatchers (Weight Watchers) logo is seen displayed on a smartphone screen. 

WW Stock Rallies 4% Pre-Market Today: What’s Powering The Rally? 

WeightWatchers partnered with Amazon Pharmacy to expand access to weight-loss medications.

Equity

Zacks.com featured highlights include WW International and Webull

New analyst coverage puts WW International and Webull in focus as investors seek insight amid inflation, tariffs, and policy uncertainty.

2 Stocks in Focus as New Analyst Initiates Coverage

New analyst coverage sparks fresh interest in WW and BULL as both stocks show stable 2025 forecasts despite recent declines.

WW International (WW), popularly known as WeightWatchers, filed for Chapter 11 bankruptcy protection on Tuesday after its business struggled for years due to the rise of weight loss drugs.The company's shares dipped over 56% in extended trading after ending up 11.2% in the regular session.Media <a href="https://stocktwits.com/news-articles/markets/equity/weightwatchers-reportedly-considers-bankruptcy-amid-business-struggles/chfoUwsRbBJ">reports</a> about the potential bankruptcy have been swirling for a few months, leading to&nbsp;a whipsawing in the company's&nbsp;stock, which&nbsp;has traded below $1 for the better part of the year; however, signals have been mixed in recent weeks.WW recently <a href="https://stocktwits.com/news-articles/markets/equity/weightwatchers-stock-rockets-after-partnership-for-eli-lillys-zepbound/chXRDYrRbLl">announced</a> a tie-up to sell Eli Lilly's (LLY) popular weight loss drug, Zepbound, through its platform. Earlier, Galloway Capital Partners <a href="https://stocktwits.com/news-articles/markets/equity/weightwatchers-bankruptcy-buzz-could-be-a-strategy-to-get-a-better-deal/chQCxFERbL3">disclosed</a> a 2.87% stake in the company and urged it not to consider bankruptcy.WW said the reorganization plan would eliminate $1.15 billion in debt from its balance sheet. The company has accumulated substantial debt of around $1.6 billion.Early this year, credit ratings firm S&amp;P Global Ratings downgraded the company's credit rating, saying that its subscriber base has aged and its brand is out of favor.WeightWatchers started as a small weekly support group focused on weight loss and rapidly evolved into a global movement, amassing millions of members worldwide.However, the surge in&nbsp;the use of GLP-1 medications — like Novo Nordisk's Wegovy and Zepbound — dampened interest in the company's conventional weight-loss offerings.After its rebrand to WW International in 2018, the company focused on overall wellness rather than just weight loss.On Stocktwits, retail sentiment&nbsp;for WW&nbsp;ended on an 'extremely bullish'&nbsp;note late Tuesday, unchanged from a week ago.<figure class="image"><img style="aspect-ratio:1286/146;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_07_at_9_31_52_AM_png_f03cce293d.webp" alt="Screenshot 2025-05-07 at 9.31.52 AM.png" width="1286" height="146"><figcaption>WW sentiment and message volume as of May 6 | Source: Stocktwits</figcaption></figure>A user noted, "Bankruptcy stocks always sky rocket after sell offs... (WW) Could triple or quadruple here this."<stembedurl>https://stocktwits.com/Cdeezhands/message/613751268</stembedurl>As of its close on Tuesday, <a href="https://stocktwits.com/symbol/WW">WW stock</a> is down 37.8% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Exterior of local Weight Watchers meeting room and store location in Staten Island, New York on June 28, 2016 in New York City. (Photo by Eugene Gologursky/Getty Images for Weight Watchers)

WeightWatchers Seeks Chapter 11 Bankruptcy Protection As GLP-1 Obesity Drugs Reshape Industry

The company said the reorganization plan would eliminate $1.15 billion in debt from its balance sheet

WW International (WW) Reports Q1 Loss, Lags Revenue Estimates

This Left-for-Dead Penny Stock Just Got a Major Boost. Should You Buy It Now?

This penny stock has received a big boost after reports of bankruptcy began to circulate.

Shares of WW International Inc. (WW), better known as WeightWatchers, swung wildly again on&nbsp;Tuesday after announcing a new tie-up to tap into the booming weight-loss drug trend.The company’s stock doubled intraday before ending the session 77% higher. It jumped over 9% in extended trading.WW said it had integrated Eli Lilly's (LLY) LillyDirect pharmacy provider, Gifthealth, into its platform to streamline access to the FDA-approved weight-loss drug, Zepbound.WeightWatchers said that eligible self-pay patients without insurance can now access prescriptions for Zepbound in single-dose vial form through the company's app.According to the company, demand for Zepbound has surged among WeightWatchers Clinic members, with prescriptions for the vial version more than doubling in recent months.Currently, 33% of&nbsp;WeightWatchers' clinic patients use Zepbound as part of their weight management regimen.On Stocktwits, retail sentiment for the company&nbsp;climbed higher within the&nbsp;'extremely bullish'&nbsp;zone.<figure class="image"><img style="aspect-ratio:810/188;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_30_at_8_59_41_AM_png_898ce16bd0.webp" alt="Screenshot 2025-04-30 at 8.59.41 AM.png" width="810" height="188"><figcaption>WW sentiment and message volume as of April 29 | Source: Stocktwits</figcaption></figure>The development comes amid bankruptcy reports and days after an activist investor disclosed its interest in the firm.Earlier this month,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/weightwatchers-reportedly-considers-bankruptcy-amid-business-struggles/chfoUwsRbBJ">reports</a> emerged that WW was considering filing for Chapter 11, leading&nbsp;to its shares plummeting 62% on a single day.On Friday, Galloway Capital Partners disclosed it owns a 2.87% stake in the company and urged it not to consider bankruptcy,&nbsp;leading to a whopping 168% spike in share price.While WeightWatchers hasn't commented on a potential bankruptcy plan, its business continues to be under pressure.The company's revenue has fallen 11% to 14% in each of the last three years, and early this year, S&amp;P Global Ratings downgraded its rating&nbsp;on the company's debt.<a href="https://stocktwits.com/symbol/WW">Shares of WeightWatchers</a> are down 42.4% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

WeightWatchers Stock Rockets After Partnership For Eli Lilly's Zepbound Drug: Retail Investors Very Optimistic

Eligible self-pay patients without insurance can now access prescriptions for Zepbound in single-dose vial form through the WeightWatchers app.

WW International, Inc. engages in the provision of weight management services. It operates through the following geographical segments: United States, Germany, and Other. The company was founded by Jean Nidetch in 1963 and is headquartered in New York, NY.

WW
WW International, Inc. Common Stock

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest WW News

WWWW International, Inc. Common Stock